28473531|t|Oncogenic RAS regulates long non-coding RNA Orilnc1 in human cancer
28473531|a|RAS and its downstream cascades transmit cellular signals resulting in increased transcription of genes involved in cell growth and division. Protein-coding gene targets of RAS signaling have been characterized extensively, but long non-coding RNAs (lncRNA) regulated by these processes have not. Using a custom-designed lncRNA microarray, we identified the lncRNA Orilnc1 as a genetic target of RAS that is critical for RAS oncogenicity. Orilnc1 expression was regulated by RAS-RAF-MEK-ERK signaling via the transcription factor AP1. Orilnc1 was highly expressed in BRAF-mutant cancers such as melanoma. Silencing of Orilnc1 blocked tumor cell proliferation and growth in vitro and in vivo. Additionally, Orilnc1 blockade reduced expression of Cyclin E1 and induced G1/S cell cycle arrest in tumor cells. Taken together, our results identify Orilnc1 as a novel, non-protein mediator of RAS/RAF activation which may serve as a therapeutic target in RAS/RAF-driven cancers.
28473531	0	13	Oncogenic RAS	T017	UMLS:C0034678
28473531	14	23	regulates	T038	UMLS:C0017263
28473531	24	51	long non-coding RNA Orilnc1	T103	UMLS:C3494264
28473531	55	60	human	T204	UMLS:C0086418
28473531	61	67	cancer	T038	UMLS:C0007097
28473531	68	71	RAS	T017	UMLS:C0034678
28473531	80	99	downstream cascades	T017	UMLS:C0017337
28473531	109	125	cellular signals	T038	UMLS:C0037083
28473531	149	171	transcription of genes	T038	UMLS:C0040649
28473531	184	195	cell growth	T038	UMLS:C0007595
28473531	200	208	division	T038	UMLS:C0007590
28473531	210	229	Protein-coding gene	T017	UMLS:C3839127
28473531	241	254	RAS signaling	T038	UMLS:C1514731
28473531	296	316	long non-coding RNAs	T103	UMLS:C3494264
28473531	318	324	lncRNA	T103	UMLS:C3494264
28473531	326	335	regulated	T038	UMLS:C0017263
28473531	426	440	lncRNA Orilnc1	T103	UMLS:C3494264
28473531	464	467	RAS	T017	UMLS:C0034678
28473531	489	492	RAS	T017	UMLS:C0034678
28473531	493	505	oncogenicity	T201	UMLS:C3828709
28473531	507	514	Orilnc1	T103	UMLS:C3494264
28473531	515	525	expression	T038	UMLS:C0017262
28473531	530	539	regulated	T038	UMLS:C0017263
28473531	543	568	RAS-RAF-MEK-ERK signaling	T038	UMLS:C0037080
28473531	577	601	transcription factor AP1	T017	UMLS:C3888349
28473531	603	610	Orilnc1	T103	UMLS:C3494264
28473531	622	631	expressed	T038	UMLS:C0017262
28473531	635	646	BRAF-mutant	T038	UMLS:C1511021
28473531	647	654	cancers	T038	UMLS:C0007097
28473531	663	671	melanoma	T038	UMLS:C0025202
28473531	673	682	Silencing	T038	UMLS:C0598496
28473531	686	693	Orilnc1	T103	UMLS:C3494264
28473531	702	726	tumor cell proliferation	T038	UMLS:C0596290
28473531	731	737	growth	T038	UMLS:C0007595
28473531	751	758	in vivo	T082	UMLS:C1515655
28473531	774	781	Orilnc1	T103	UMLS:C3494264
28473531	799	809	expression	T038	UMLS:C1171362
28473531	813	822	Cyclin E1	T103	UMLS:C1259807
28473531	835	857	G1/S cell cycle arrest	T038	UMLS:C1517339
28473531	861	872	tumor cells	T017	UMLS:C0597032
28473531	911	918	Orilnc1	T103	UMLS:C3494264
28473531	955	973	RAS/RAF activation	T038	UMLS:C2265359
28473531	1017	1039	RAS/RAF-driven cancers	T038	UMLS:C0007097